COVID-19 TREATMENT TRIAL
Overview of COVID-19 Medical Research Study
This study is to monitor the safety and efficiency for the treatment called G5-5245 for COVID-19 in people who have a standard risk of becoming seriously ill. The study will also measure how much GS-5245 gets into the blood and how long it takes the body to get rid of it. Taking part in this study will last approximately 91days including the screening visit.
You may be eligible to take part in the study if you:
• Are at least 18 years of age or older
• Must have positive testing of SARS CoV-2 in past 3 days
• Must have SAR-CoV-2 Symptoms no longer than 3 days
You may be compensated for time and travel, up to $1339 for your time and participation
Contact us today to learn more about our current study opportunity. Signup online by completing the contact form below, or email our Patient Recruitment Specialist, Autumn Wofford at email@example.com. You can reach us via Phone at 803.764.2406.